(Press-News.org) Contact information: Nora Dudley
nodudley@lumc.edu
708-216-6268
Loyola University Health System
Osteoporosis drugs compared for side effects, efficacy in Loyola study
A study comparing the efficacy and tolerability of two popular osteoporosis drugs, denosumab and zoledronic acid, found that denosumab had a significantly greater effect on increasing spine bone mineral density and zoledronic acid caused more flulike symptoms. These findings were presented recently at the American Society for Bone and Mineral Research's annual meeting.
Researchers performed a retrospective chart review and survey of 107 patients to compare the efficacy, patient satisfaction, cost and known adverse effects of denosumab versus zoledronic acid, including muscle pain, back pain and flulike symptoms. The denosumab and zoledronic acid groups were statistically similar in all areas but spine bone mineral density (increased 0.060 g/cm2 versus 0.021 g/cm2, respectively) and flulike symptoms (none versus 29 percent of patients).
"Both groups of patients were satisfied with their treatment despite the discrepancies in the drugs," said Kellen Sheedy, first author and Stritch School of Medicine student.
The FDA approved denosumab in 2010 for postmenopausal women with osteoporosis. It is injected subcutaneously (60 mg) every six months. The treatment works by inhibiting bone loss and fracture risk.
Zoledronic acid was approved by the FDA in 2007 for osteoporosis. This treatment is administered intravenously (5 mg) once every 12 months. It is the most potent of the drugs in its class, and it works by interfering with the bone-breakdown process.
"This study helped us quantify the efficacy and adverse effects of these two drugs providing further guidance for physicians who prescribe these treatments," said Pauline Camacho, MD, study investigator and director of the Osteoporosis & Metabolic Bone Disease Center at Loyola University Health System. "While this was the first head-to-head comparison of these two treatments, larger prospective studies will be needed to confirm these findings."
### END
Osteoporosis drugs compared for side effects, efficacy in Loyola study
2013-12-03
ELSE PRESS RELEASES FROM THIS DATE:
Micromovements hold hidden information about severity of autism, researchers report
2013-12-03
Micromovements hold hidden information about severity of autism, researchers report
INDIANAPOLIS -- Movements so minute they cannot be detected by the human eye are being analyzed by researchers to diagnose autism spectrum disorder and determine its severity in children and ...
Vitamin D decreases pain in women with type 2 diabetes and depression
2013-12-03
Vitamin D decreases pain in women with type 2 diabetes and depression
Vitamin D decreases pain in women with type 2 diabetes and depression, according to a study conducted at Loyola University Chicago. These findings were presented at an Oct. 24, 2013 research ...
Airborne radar looking through thick ice during NASA polar campaigns
2013-12-03
Airborne radar looking through thick ice during NASA polar campaigns
The bedrock hidden beneath the thick ice sheets covering Greenland and Antarctica has intrigued researchers for years. Scientists are interested in how the shape of this hidden terrain ...
New technique identifies pathogens in patient samples faster, in great detail
2013-12-03
New technique identifies pathogens in patient samples faster, in great detail
A team of Danish investigators has shown how to identify pathogens faster, directly from clinical samples. The research, published online ahead of print in the Journal of Clinical ...
New research shows promise for possible HIV cure
2013-12-03
New research shows promise for possible HIV cure
CHICAGO – Researchers have used radioimmunotherapy (RIT) to destroy remaining human immunodeficiency virus (HIV)-infected cells in the blood samples of patients treated with antiretroviral therapy, offering ...
Breast tomosynthesis increases cancer detection and reduces recall rates
2013-12-03
Breast tomosynthesis increases cancer detection and reduces recall rates
CHICAGO – Researchers have found that digital breast tomosynthesis (DBT) led to reduced recall rates and an increase in cancer detection in a large breast cancer screening program. ...
Breast cancer risk related to changes in breast density as women age
2013-12-03
Breast cancer risk related to changes in breast density as women age
CHICAGO – Automated breast density measurement is predictive of breast cancer risk in younger women, and that risk may be related to the rate at which breast density changes in some women ...
International study finds heart disease similar in men and women
2013-12-03
International study finds heart disease similar in men and women
CHICAGO – An analysis of data from an international multicenter study of coronary computed tomography angiography (CCTA) reveals that men and women with mild coronary artery disease and similar ...
Disability, distress in RA patients cut in half over last 20 years
2013-12-03
Disability, distress in RA patients cut in half over last 20 years
New research reveals that patients with rheumatoid arthritis (RA) today have an easier time with daily living than patients diagnosed two decades ago. According to results of the study published in Arthritis Care ...
3D mammography increases cancer detection and reduces call-back rates, Penn study finds
2013-12-03
3D mammography increases cancer detection and reduces call-back rates, Penn study finds
CHICAGO—Compared to traditional mammography, 3D mammography—known as digital breast tomosynthesis—found 22 percent more breast cancers and led ...